{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:42:02Z","timestamp":1740170522328,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2020jcyj-msxmX1093"],"award-info":[{"award-number":["cstc2020jcyj-msxmX1093"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"DOI":"10.1007\/s40520-022-02293-8","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T04:18:41Z","timestamp":1667362721000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of examined lymph node count in older patients with stage T1N0M0 pulmonary carcinoid tumours: a population-based propensity score-matched analysis"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-012X","authenticated-orcid":false,"given":"Hao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanglan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"2293_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJM199903183401107","volume":"340","author":"MH Kulke","year":"1999","unstructured":"Kulke MH, Mayer RJ (1999) Carcinoid tumors. New Engl J Med 340:858","journal-title":"New Engl J Med"},{"key":"2293_CR2","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s40520-022-02112-0","volume":"34","author":"H Yang","year":"2022","unstructured":"Yang H, Xiao X, Mei T et al (2022) Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study. Aging Clin Exp Res 34:1925\u20131934. https:\/\/doi.org\/10.1007\/s40520-022-02112-0","journal-title":"Aging Clin Exp Res"},{"key":"2293_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cllc.2020.12.004","volume":"22","author":"N Prinzi","year":"2021","unstructured":"Prinzi N, Rossi RE, Proto C et al (2021) Recent advances in the management of typical and atypical lung carcinoids. Clin Lung Cancer 22:161","journal-title":"Clin Lung Cancer"},{"key":"2293_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.annonc.2021.01.003","volume":"32","author":"E Baudin","year":"2021","unstructured":"Baudin E, Caplin M, Garcia-Carbonero R et al (2021) Lung and thymic carcinoids: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol 32:439","journal-title":"Ann Oncol"},{"key":"2293_CR5","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/cancers13081753","volume":"13","author":"S Shah","year":"2021","unstructured":"Shah S, Gosain R, Groman A et al (2021) Incidence and survival outcomes in patients with lung neuroendocrine neoplasms in the United States. Cancers (Basel) 13:1753 . https:\/\/doi.org\/10.3390\/cancers13081753","journal-title":"Cancers (Basel)"},{"key":"2293_CR6","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A et al (2008) One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063","journal-title":"J Clin Oncol"},{"key":"2293_CR7","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.21037\/jtd.2018.09.141","volume":"10","author":"M Furqan","year":"2018","unstructured":"Furqan M, Tien YY, Schroeder MC et al (2018) Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis. J Thorac Dis 10:5850\u20135859. https:\/\/doi.org\/10.21037\/jtd.2018.09.141","journal-title":"J Thorac Dis"},{"key":"2293_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejcts.2006.10.040","volume":"31","author":"F Rea","year":"2007","unstructured":"Rea F, Rizzardi G, Zuin A et al (2007) Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients. Eur J Cardiothorac Surg 31:186\u2013191. https:\/\/doi.org\/10.1016\/j.ejcts.2006.10.040","journal-title":"Eur J Cardiothorac Surg"},{"key":"2293_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.610638","volume":"11","author":"B Zhang","year":"2021","unstructured":"Zhang B, Liu R, Ren D et al (2021) Comparison of lobectomy and sublobar resection for stage IA elderly NSCLC patients (\u226570 years): a population-based propensity score matching\u2019s study. Front Oncol 11:610638. https:\/\/doi.org\/10.3389\/fonc.2021.610638","journal-title":"Front Oncol"},{"key":"2293_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120510","author":"R Gosain","year":"2018","unstructured":"Gosain R, Mukherjee S, Yendamuri SS et al (2018) Management of typical and atypical pulmonary carcinoids based on different established guidelines. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers10120510","journal-title":"Cancers (Basel)"},{"key":"2293_CR11","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00432-017-2499-y","volume":"143","author":"C Gu","year":"2017","unstructured":"Gu C, Wang R, Pan X et al (2017) Sublobar resection versus lobectomy in patients aged \u226435 years with stage IA non-small cell lung cancer: a SEER database analysis. J Cancer Res Clin Oncol 143:2375\u20132382. https:\/\/doi.org\/10.1007\/s00432-017-2499-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"2293_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jtho.2016.11.2222","volume":"12","author":"AE Hendifar","year":"2017","unstructured":"Hendifar AE, Marchevsky AM, Tuli R (2017) Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease. J Thorac Oncol 12:425\u2013436. https:\/\/doi.org\/10.1016\/j.jtho.2016.11.2222","journal-title":"J Thorac Oncol"},{"key":"2293_CR13","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.21037\/jtd-20-2221","volume":"12","author":"W Wang","year":"2020","unstructured":"Wang W, Sun Y, Li H et al (2020) Surgical modality for stage IA non-small cell lung cancer among the elderly: analysis of the surveillance, epidemiology, and end results database. J Thorac Dis 12:6731\u20136742. https:\/\/doi.org\/10.21037\/jtd-20-2221","journal-title":"J Thorac Dis"},{"key":"2293_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jss.2015.08.045","volume":"200","author":"SS Razi","year":"2016","unstructured":"Razi SS, John MM, Sainathan S et al (2016) Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a surveillance, epidemiology, and end results database analysis. J Surg Res 200:683\u2013689. https:\/\/doi.org\/10.1016\/j.jss.2015.08.045","journal-title":"J Surg Res"},{"key":"2293_CR15","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1200\/JCO.2016.67.5140","volume":"35","author":"W Liang","year":"2017","unstructured":"Liang W, He J, Shen Y et al (2017) Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: a population study of the US SEER database and a Chinese multi-institutional registry. J Clin Oncol 35:1162\u20131170. https:\/\/doi.org\/10.1200\/JCO.2016.67.5140","journal-title":"J Clin Oncol"},{"key":"2293_CR16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12215-7","author":"X Cheng","year":"2022","unstructured":"Cheng X, Zeng W, Liu Y et al (2022) Impact of lymph node dissection on survival and tumor recurrence for patients with resected cT1-2N0 small cell lung cancer. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-022-12215-7","journal-title":"Ann Surg Oncol"},{"key":"2293_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.lungcan.2022.06.018","volume":"170","author":"Y Wo","year":"2022","unstructured":"Wo Y, Li H, Zhang Y et al (2022) The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer. Lung Cancer 170:141\u2013147. https:\/\/doi.org\/10.1016\/j.lungcan.2022.06.018","journal-title":"Lung Cancer"},{"key":"2293_CR18","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/1759-7714.14456","volume":"13","author":"MZ Yang","year":"2022","unstructured":"Yang MZ, Tan ZH, Li JB et al (2022) Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: a propensity score matching study. Thorac Cancer 13:2106\u20132116. https:\/\/doi.org\/10.1111\/1759-7714.14456","journal-title":"Thorac Cancer"},{"key":"2293_CR19","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/j.cllc.2021.09.007","volume":"23","author":"M Nakao","year":"2022","unstructured":"Nakao M, Saji H, Mun M et al (2022) Prognostic impact of mediastinal lymph node dissection in octogenarians with lung cancer: JACS1303. Clin Lung Cancer 23:e176\u2013e184. https:\/\/doi.org\/10.1016\/j.cllc.2021.09.007","journal-title":"Clin Lung Cancer"},{"key":"2293_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00595-021-02373-8","volume":"52","author":"T Maniwa","year":"2022","unstructured":"Maniwa T, Kimura T, Ohue M et al (2022) Mediastinal lymph node dissection in older patients with non-small cell lung cancer. Surg Today 52:458\u2013464. https:\/\/doi.org\/10.1007\/s00595-021-02373-8","journal-title":"Surg Today"},{"key":"2293_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac359","author":"A Kamigaichi","year":"2022","unstructured":"Kamigaichi A, Aokage K, Katsumata S et al (2022) Prognostic impact of examined mediastinal lymph node count in clinical N0 non-small cell lung cancer. Eur J Cardiothorac Surg. https:\/\/doi.org\/10.1093\/ejcts\/ezac359","journal-title":"Eur J Cardiothorac Surg"},{"key":"2293_CR22","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1016\/j.cllc.2020.09.015","volume":"22","author":"Z He","year":"2021","unstructured":"He Z, Li Z, Xu S et al (2021) Prognostic significance of lymph node count removed at sublobar resection in pathologic stage IA non-small-cell lung cancer: a population-based analysis. Clin Lung Cancer 22:e563\u2013e573. https:\/\/doi.org\/10.1016\/j.cllc.2020.09.015","journal-title":"Clin Lung Cancer"},{"key":"2293_CR23","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-020-09217-8","volume":"28","author":"YZ Zheng","year":"2021","unstructured":"Zheng YZ, Li XQ, Wang JY et al (2021) Impact of examined lymph node count for esophageal squamous cell carcinoma in patients who underwent right transthoracic esophagectomy. Ann Surg Oncol 28:3025\u20133033. https:\/\/doi.org\/10.1245\/s10434-020-09217-8","journal-title":"Ann Surg Oncol"},{"key":"2293_CR24","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.ejso.2020.04.047","volume":"46","author":"YZ Zheng","year":"2020","unstructured":"Zheng YZ, Li XQ, Wang JY et al (2020) Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy. Eur J Surg Oncol 46:1956\u20131962. https:\/\/doi.org\/10.1016\/j.ejso.2020.04.047","journal-title":"Eur J Surg Oncol"},{"key":"2293_CR25","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1111\/cas.15003","volume":"112","author":"L Zhao","year":"2021","unstructured":"Zhao L, Han W, Yang X et al (2021) Exceeding 30 ELNs is strongly recommended for pT3-4N0 patients with gastric cancer: a multicenter study of survival, recurrence, and prediction model. Cancer Sci 112:3266\u20133277. https:\/\/doi.org\/10.1111\/cas.15003","journal-title":"Cancer Sci"},{"key":"2293_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.539030","volume":"10","author":"L Huang","year":"2020","unstructured":"Huang L, Zhang X, Wei Z et al (2020) Importance of examined lymph node number in accurate staging and enhanced survival in resected gastric adenocarcinoma-the more, the better? A cohort study of 8696 cases from the US and China, 2010\u20132016. Front Oncol 10:539030. https:\/\/doi.org\/10.3389\/fonc.2020.539030","journal-title":"Front Oncol"},{"key":"2293_CR27","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.2217\/fon-2021-0113","volume":"17","author":"H Feng","year":"2021","unstructured":"Feng H, Lyu Z, Liang W et al (2021) Optimal examined lymph node count in node-negative colon cancer should be determined. Future Oncol 17:3865\u20133872. https:\/\/doi.org\/10.2217\/fon-2021-0113","journal-title":"Future Oncol"},{"key":"2293_CR28","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/jso.26168","volume":"122","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wu YH, Cai ZQ et al (2020) Optimal number of harvested lymph nodes for curatively resected gallbladder adenocarcinoma based on a Bayesian network model. J Surg Oncol 122:1409\u20131417. https:\/\/doi.org\/10.1002\/jso.26168","journal-title":"J Surg Oncol"},{"key":"2293_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1200\/JCO.2003.07.010","volume":"21","author":"A Gajra","year":"2003","unstructured":"Gajra A, Newman N, Gamble GP et al (2003) Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21:1029\u20131034. https:\/\/doi.org\/10.1200\/JCO.2003.07.010","journal-title":"J Clin Oncol"},{"key":"2293_CR30","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.21037\/jtd.2018.11.49","volume":"10","author":"Y Liu","year":"2018","unstructured":"Liu Y, Shen J, Liu L et al (2018) Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection. J Thorac Dis 10:6569\u20136577. https:\/\/doi.org\/10.21037\/jtd.2018.11.49","journal-title":"J Thorac Dis"},{"key":"2293_CR31","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252\u20137259. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713","journal-title":"Clin Cancer Res"},{"key":"2293_CR32","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/ejcts\/ezab287","volume":"60","author":"H Yang","year":"2021","unstructured":"Yang H, Mei T (2021) The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database. Eur J Cardiothorac Surg 60:1212\u20131220. https:\/\/doi.org\/10.1093\/ejcts\/ezab287","journal-title":"Eur J Cardiothorac Surg"},{"key":"2293_CR33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB et al (2022) The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol 17:362\u2013387. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.003","journal-title":"J Thorac Oncol"},{"key":"2293_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.21037\/tlcr.2017.09.04","volume":"6","author":"G Pelosi","year":"2017","unstructured":"Pelosi G, Sonzogni A, Harari S et al (2017) Classification of pulmonary neuroendocrine tumors: new insights. Transl Lung Cancer Res 6:513\u2013529. https:\/\/doi.org\/10.21037\/tlcr.2017.09.04","journal-title":"Transl Lung Cancer Res"},{"key":"2293_CR35","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.athoracsur.2020.04.117","volume":"110","author":"AJ Rucker","year":"2020","unstructured":"Rucker AJ, Raman V, Jawitz OK et al (2020) Effect of lymph node assessment on outcomes in surgery for limited stage small cell lung cancer. Ann Thorac Surg 110:1854\u20131860. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.04.117","journal-title":"Ann Thorac Surg"},{"key":"2293_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.athoracsur.2017.07.049","volume":"105","author":"LM Brown","year":"2018","unstructured":"Brown LM, Cooke DT, Jett JR et al (2018) Extent of resection and lymph node assessment for clinical stage T1aN0M0 typical carcinoid tumors. Ann Thorac Surg 105:207\u2013213. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.07.049","journal-title":"Ann Thorac Surg"},{"key":"2293_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.athoracsur.2018.05.044","volume":"106","author":"PJ Kneuertz","year":"2018","unstructured":"Kneuertz PJ, Kamel MK, Stiles BM et al (2018) Incidence and prognostic significance of carcinoid lymph node metastases. Ann Thorac Surg 106:981","journal-title":"Ann Thorac Surg"},{"key":"2293_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00408-017-0056-8","volume":"195","author":"G Cusumano","year":"2017","unstructured":"Cusumano G, Fournel L, Strano S et al (2017) Surgical resection for pulmonary carcinoid: long-term results of multicentric study-the importance of pathological N status, more than we thought. Lung 195:789\u2013798. https:\/\/doi.org\/10.1007\/s00408-017-0056-8","journal-title":"Lung"},{"key":"2293_CR39","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/aje\/kwab041","volume":"190","author":"T St\u00fcrmer","year":"2021","unstructured":"St\u00fcrmer T, Webster-Clark M, Lund JL et al (2021) Propensity score weighting and trimming strategies for reducing variance and bias of treatment effect estimates: a simulation study. Am J Epidemiol 190:1659\u20131670. https:\/\/doi.org\/10.1093\/aje\/kwab041","journal-title":"Am J Epidemiol"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-022-02293-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:44:38Z","timestamp":1672976678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-022-02293-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["2293"],"URL":"https:\/\/doi.org\/10.1007\/s40520-022-02293-8","relation":{},"ISSN":["1720-8319"],"issn-type":[{"type":"electronic","value":"1720-8319"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"23 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As the data used were from SEER dataset (accession number: 10466-Nov2021), which is publicly available, ethics approval and consent to participate is not applicable. The study was approved (or granted exemption) by the appropriate institutional and\/or national research ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}